Biomarkers in Medicine（医学生物标志物杂志）影响因子_期刊投稿发表

期刊简介

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.

生物标志物是生理或疾病过程的物理、功能或生化指标。这些关键指标可为确定疾病预后、预测治疗反应、不良事件和药物相互作用以及建立基线风险提供重要信息。对生物标志物研究兴趣的爆发正在推动现代医疗实践中新的预测、诊断和预后产品的开发，生物标志物在新药的发现和开发中也发挥着越来越重要的作用。为了实现生物标志物的充分利用，我们需要更深入地了解疾病机制，以及疾病机制、治疗干预和拟议生物标志物之间的相互作用。然而，在试图系统地评估生物标志物的利弊时，我们正在进入一个新的、具有挑战性的领域。《生物标志物在医学中》（ISSN 1752-0363）是一本同行评审的、快速出版的期刊，它提供了我们对生物标志物及其在医学中的潜在和实际应用的理解进展的评论和分析。随着医学和药物开发中生物标志物的科学原理和监管接受度越来越全面，生物标志物在临床中的应用也越来越广泛，医学生物标志物为这一日益重要的领域的所有参与者提供了一个平台，以交流和讨论与潜在效用和应用有关的所有问题。每一期都包括各种各样的内容，为研究专业人士提供全面的报道。文章包括客座社论，访谈，评论，研究文章，观点，优先论文评估，特别报告，案例报告，会议报告和公司简介。综述报道根据治疗效用的领域分为主题部分，其中一些问题包括主题部分的主题感兴趣的领域。医学生物标志物为所有专业人士提供了一个评论和辩论的平台，他们对生物标志物的鉴定，阐明其作用，以及其在现代医学中的应用的正式化和批准感兴趣。医学生物标志物的受众包括学术和工业研究人员、临床医生、病理学家、临床化学家和监管专业人士。

《Biomarkers in Medicine》期刊已被查看：次